Go to content

Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease


No abstract available.



Naylor KL, McArthur E, Dixon SN, Kwong JC, Thomas D, Balamchi S, Blake PG, Garg AX, Atiqazaaman M, Hladunewich MA, Levin A, Yeung A, Oliver MJ. Kidney Int. 2023; 103(4):791-7. Epub 2023 Jan 30.

View Source

Associated Sites